SynthesisPediatric surgery international2026
Thoracoscopic versus open congenital diaphragmatic hernia repair: a systematic review and meta-analysis by the Pediatric Surgery Meta-Analysis Study Group (PESMA).
Synthesis in Pediatric surgery international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Adaptability of minimally invasive thoracoscopic repair for congenital diaphragmatic hernia: a neonatal case report from a low-income country.International journal of surgery case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo compare outcomes of thoracoscopic repair (TR) versus conventional open repair (COR) for congenital diaphragmatic hernia (CDH) through a systematic review and meta-analysis.
methodsPubMed, EMBASE, SCOPUS, and Web of Science were searched up to August 2025 for comparative neonatal CDH studies. Randomized, prospective, and retrospective designs reporting at least one clinical outcome were included. Risk ratios (RR) with 95% confidence intervals (CI) were pooled using a random-effects model. The review followed PRISMA guidelines and was registered in PROSPERO (CRD420251128490).
resultsNineteen studies involving 434 TR and 631 COR cases were included. Total recurrence was higher after TR (12.9% vs. 4.1%; RR 2.40; p = 0.0003). Primary repair recurrence showed the largest difference (12% vs. 0%; RR 4.39; p = 0.001), and patch repair recurrence remained higher in TR (21% vs. 11.5%; RR 1.98; p = 0.04). Bowel obstruction was lower after TR (6% vs. 14.6%; RR 0.52; p = 0.02). No significant differences were found for chylothorax, pneumothorax, pleural effusion, or bowel injury. Mortality was lower in TR (0.9% vs. 5.9%; RR 0.31; p < 0.0001), likely reflecting patient selection.
conclusionTR is feasible in selected neonates and is associated with lower bowel obstruction and mortality but higher recurrence. Standardized criteria for selecting TR versus COR remain essential.
Indexed as
Identifiers
42014582What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.